Highlights:
- India administers 100 crore COVID-19 vaccines
- India also conquered 10 milestones after reaching the 100 crore vaccination mark
- Prime Minister Narendra Modi tweeted after India crosses the 100 crore mark
On Thursday, India crossed another milestone in its COVID-19 vaccination drive when the overall vaccination administered crossed the 100 crore mark. A total of 100 crore vaccine doses have been administered so far to the eligible beneficiaries, according to the data on the Cowin portal at quarter to 10 in the morning on Thursday.
Mansukh Mandaviya, Union Health Minister, congratulated the citizens of the country on achieving such a huge milestone.
Prime Minister Narendra Modi, too, congratulated the people of India and thanked the front line workers. PM Modi tweeted, “India scripts history. We are witnessing the triumph of Indian science, enterprise and collective spirit of 130 crore Indians. Congrats India on crossing 100 crore vaccinations. Gratitude to our doctors, nurses and all those who worked to achieve this feat. #VaccineCentury”.
India scripts history.
— Narendra Modi (@narendramodi) October 21, 2021
We are witnessing the triumph of Indian science, enterprise and collective spirit of 130 crore Indians.
Congrats India on crossing 100 crore vaccinations. Gratitude to our doctors, nurses and all those who worked to achieve this feat. #VaccineCentury
Union Health Minister Tweeted, “Congratulations India! This is the result of the able leadership of visionary Prime Minister Narendra Modi. #VaccineCentury,” in Hindi.
बधाई हो भारत!
— Dr Mansukh Mandaviya (@mansukhmandviya) October 21, 2021
दूरदर्शी प्रधानमंत्री श्री @NarendraModi जी के समर्थ नेतृत्व का यह प्रतिफल है।#VaccineCentury pic.twitter.com/11HCWNpFan
The Health Minister’s office informed that Mandaviya will launch a song along with an audio-visual film to celebrate India’s milestone of 100 crore Covid-19 vaccinations at the Red Fort, today.
The office of the minister said, “Dr Mansukh Mandaviya will launch a song and audio-visual film to celebrate India’s milestone of 100 crore #COVID19 vaccinations”.
Also Read: UP’s Kushinagar Witnesses Launch Of New International Airport, PM Modi Presides Inaugural Ceremony
Let us see India’s journey to 100 crore COVID-19 vaccine doses and the milestones along the way:
1) The feat was achieved in under 10 months of the starting of India’s COVID-19 vaccination drive on January 16.
2) To vaccinate the country’s huge population, the Drugs Controller General of India (DCGI) gave green light to the Oxford-AstraZeneca COVID-19 vaccine – Covishield (manufactured under licence by Serum Institute of India) as well as Covaxin (India’s indigenous vaccine developed by Bharat Biotech), on January 3.
3) In phase 1 of the vaccination drive, launched on January 16, all health care and frontline workers were eligible to take the jabs.
4) On March 1, the next phase of the inoculation programme started, making the population over 60 years, and those above 45-years of age with co-morbidities eligible for vaccination. The programme was extended to all above 45 years of age on April 1.
5) On April 13, the DCGI also approved the use of Russia’s Sputnik V vaccine (manufactured under license by Dr Reddy’s Laboratories).
6) The national immunisation programme against COVID-19 vaccine was expanded for the entire adult population which means anyone 18 years old or above can get the COVID-19 jab, on May 1.
7) on 20th August, World’s first DNA-based Covid vaccine by the Indian pharmaceutical company Zydus Cadila was given the approval. It is a three-shot vaccine and the population base above 12 years of age can be inoculated with it. It is expected to hit the markets soon.
8) On the 17th of September, the country, for the first time, crossed the “two crore doses a day” mark. More than 2.15 crore jabs were given that day.
9) On the 4th of October, to connect remote areas of the country, the health ministry started drone delivery of Covid vaccines.
10) On the 12th of October, the Subject Expert Committee (SEC) of the drug regulator also recommended granting an emergency use authorisation to Covaxin, developer by Bharat Biotech for children aged between 2-17 years as well.